Literature DB >> 8444581

Intensive care in an Irish district general hospital--a three year review.

M G Davies1, J A Connolly, G O'Kane, K Murphy, C McDowell, M F Shine, F Lennon.   

Abstract

The International Missionary Training Hospital is a 340-bed acute general hospital with maternity and paediatric units. It serves a population of 120,000 people within the North Eastern Health Board Area and has approximately 14,000 admissions each year. This report retrospectively reviews the activity of a three bedded, Intensive Therapy Unit (ITU) over the three year period July 1987-June 1990. 805 patients (1.9% of hospital admissions) with an average age of 55 +/- 22 years (mean +/- SD, range 14-94 years) were admitted to the unit. There were 458 males (57%) and 347 females (43%). 68% of the patients were admitted from the general wards and the remainder from the accident unit. 59% of the admissions were immediate postoperative cases. 82% of patients had APACHE scores less than 20. There was a wide diversity of medical and surgical diagnoses requiring treatment. 219 cases required one or more systems to be supported and 586 (73%) were admitted as high dependency cases. For those requiring ventilation, the average ventilation time was 3.2 days (range 0.5-23 days). The average length of stay within in the unit was 2.3 days (range 1-23 days). 86% of the patients were discharged to the wards, 11% died and 3% were transferred to external specialist care facilities. ITU's in district general hospitals serve as both critical care areas and high dependency units. In our opinion they produce a positive contribution to progressive patient care for high risk medical and surgical patients.

Entities:  

Mesh:

Year:  1993        PMID: 8444581

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  1 in total

1.  Intensive care in a general hospital: demographics, utilization and outcomes.

Authors:  E Slattery; N Basavaraju; S Ahmed; G Kaur; A Hegarty; M Ahmed; J Dilip; C McGurk
Journal:  Ir J Med Sci       Date:  2014-01-28       Impact factor: 1.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.